SillaJen Biotherapeutics, Inc. – Trademark Portfolio
Entity Type: 03
SillaJen Biotherapeutics, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SILLAJEN BIOTHERAPEUTICS and TARGETING, ATTACKING AND ERADICATING CANCERS. The owner is based in San Francisco, CA.
425 California Street, Suite 1200
San Francisco, CA 94104
Showing of trademarks Trademarks
Trademark Classifications
SillaJen Biotherapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SillaJen Biotherapeutics, Inc. have?
SillaJen Biotherapeutics, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 6 cancelled.
What trademark classes does SillaJen Biotherapeutics, Inc. file in?
SillaJen Biotherapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are SillaJen Biotherapeutics, Inc.'s most well-known trademarks?
SillaJen Biotherapeutics, Inc.'s registered trademark portfolio includes well-known marks such as SILLAJEN BIOTHERAPEUTICS and TARGETING, ATTACKING AND ERADICATING CANCERS. These are among 2 currently registered trademarks in the portfolio.
What is SillaJen Biotherapeutics, Inc.'s trademark registration success rate?
SillaJen Biotherapeutics, Inc. has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.